NCT06902415Recruiting
Application of QDSA Platform in Cerebrovascular Diseases
Research on the Application of Quantitative Digital Subtraction Angiography Hemodynamic Analysis Platform in Cerebrovascular Diseases
Source: ClinicalTrials.gov · Last updated 30 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Cerebrovascular diseases pose a major global public health challenge, characterized by exceptionally high mortality and disability rates, with their pathogenesis closely linked to hemodynamic abnormalities. The quantitative digital subtraction angiography (QDSA) analysis platform, leveraging its advantages of vessel modeling-free operation, high computational efficiency, and DSA-equivalent sensitivity, has emerged as a novel hemodynamic assessment method with significant clinical potential. This study aims to establish a cerebrovascular disease cohort incorporating QDSA parameters to systematically validate the clinical value of this technology in preoperative evaluation and surgical planning, thereby providing evidence-based insights for optimizing diagnostic and therapeutic strategies.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 24 Mar 2025
- Start date
- Apr 2025
- Primary completion date
- Feb 2030
- Lead sponsor
- Beijing Tiantan Hospital
- Diseases
- Stroke
- NCT number
- NCT06902415
What you commit to
- Study type: Observational
- Planned participants: 1000
- From Apr 2025 to the primary completion date, Feb 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Cerebrovascular diseases not diagnosed or risk-assessed using DSA.
- Severe organ diseases with an expected survival period of less than 2 years.
- Other conditions deemed by the investigator as unsuitable for participation in this trial.
Other
- Patients with DSA image quality insufficient for image analysis and processing.
- Inability to cooperate with treatment and follow-up.
- Participation in other clinical trials within the past 6 months.
Who the study is looking for
- Cerebrovascular diseases diagnosed and assessed by DSA for related risks and treatment options.
- The DSA acquisition protocol complies with the standard procedure.
- DSA images must include complete anteroposterior and lateral views.
- Raw data must be available in DICOM format.
- Image quality and pixel resolution must support data analysis.
- Patients must undergo regular follow-ups.
Age in the registry: 1 year to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Beijing Tiantan Hospital Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.